LMO2, LIM domain only 2, 4005

N. diseases: 83; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 Biomarker disease BEFREE LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis. 31366618 2019
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 AlteredExpression disease BEFREE Lmo2 expression defines tumor cell identity during T-cell leukemogenesis. 29880602 2018
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 AlteredExpression disease BEFREE The combined results of this study provide evidence that the H3K9-me1/2 demethylase KDM3B might play a role in leukemogenesis via activation of lmo2 through interdependent actions with the histone acetyltransferase (HAT) complex containing CBP. 22615488 2012
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 Biomarker disease BEFREE These data suggest that both Lmo2 and Bcl-2 are required for the action of E2A-HLF in leukemogenesis. 21072044 2011
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 AlteredExpression disease BEFREE Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19). 20519628 2010
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 GeneticVariation disease BEFREE Furthermore, we debate whether the integration near the LMO2 locus is sufficient to result in T-ALL-like proliferations or whether the gamma-retroviral viral expression of the therapeutic IL2RG gene contributes to leukemogenesis. 17726455 2007
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 AlteredExpression disease BEFREE Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy. 17268520 2007
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 Biomarker disease BEFREE This cell line will be useful for investigating the role of RBTN2 in leukemogenesis and the mechanism by which the translocation alters the expression of RBTN2. 7475267 1995
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 AlteredExpression disease BEFREE Although RBTN-2 is crucial for normal erythropoiesis, the ectopic expression of RBTN-2 in T lymphocytes results in T-cell proliferation and leukemogenesis. 7544155 1995